Myambutol: Targeted Tuberculosis Treatment for Effective Management
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.22 (0%) | 🛒 Add to cart |
| 90 | $0.55 | $64.83 $49.25 (24%) | 🛒 Add to cart |
| 120 | $0.46 | $86.44 $55.28 (36%) | 🛒 Add to cart |
| 180 | $0.38 | $129.65 $68.34 (47%) | 🛒 Add to cart |
| 270 | $0.32 | $194.48 $86.44 (56%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $259.31 $104.53 (60%) | 🛒 Add to cart |
| Product dosage: 600mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.94 | $56.28 (0%) | 🛒 Add to cart |
| 90 | $0.77 | $84.43 $69.35 (18%) | 🛒 Add to cart |
| 120 | $0.69 | $112.57 $82.42 (27%) | 🛒 Add to cart |
| 180 | $0.61 | $168.85 $109.55 (35%) | 🛒 Add to cart |
| 270 | $0.55 | $253.28 $147.74 (42%) | 🛒 Add to cart |
| 360 | $0.53
Best per pill | $337.70 $189.96 (44%) | 🛒 Add to cart |
| Product dosage: 800mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.90 | $54.27 (0%) | 🛒 Add to cart |
| 90 | $0.82 | $81.41 $73.37 (10%) | 🛒 Add to cart |
| 120 | $0.78 | $108.55 $93.47 (14%) | 🛒 Add to cart |
| 180 | $0.74 | $162.82 $132.67 (19%) | 🛒 Add to cart |
| 270 | $0.71 | $244.23 $190.96 (22%) | 🛒 Add to cart |
| 360 | $0.69
Best per pill | $325.64 $247.25 (24%) | 🛒 Add to cart |
Synonyms | |||
Myambutol (ethambutol hydrochloride) is a first-line antimycobacterial agent specifically indicated for the treatment of pulmonary tuberculosis. It is used in combination with other antituberculosis drugs to prevent the emergence of resistance and to enhance therapeutic efficacy. This bacteriostatic medication works by inhibiting the synthesis of arabinogalactan, a critical component of the mycobacterial cell wall. Proper administration under medical supervision is essential to maximize benefits and minimize risks, particularly concerning ocular health.
Features
- Active ingredient: Ethambutol hydrochloride
- Available in 100 mg and 400 mg film-coated tablets
- Selective action against Mycobacterium tuberculosis complex
- Oral administration with high bioavailability
- Requires prescription and professional medical oversight
Benefits
- Effectively suppresses mycobacterial growth when used in combination therapy
- Reduces the risk of developing drug-resistant tuberculosis strains
- Allows for shorter, more manageable treatment regimens when protocol-adherent
- Contributes to higher cure rates in properly supervised patients
- Oral formulation supports outpatient treatment and improves compliance
- Cost-effective component of standard tuberculosis management protocols
Common use
Myambutol is primarily used as part of a multi-drug regimen for the treatment of all forms of pulmonary tuberculosis. It is always administered in combination with other antitubercular drugs such as isoniazid, rifampin, and pyrazinamide to prevent the development of resistance. The medication may also be used in certain cases of atypical mycobacterial infections, though this constitutes off-label use requiring specialist evaluation. Treatment typically continues for 6-9 months depending on disease severity, drug susceptibility patterns, and patient response.
Dosage and direction
Dosage is weight-based and must be calculated precisely according to patient body weight. The recommended dosage for adults and children is 15-25 mg/kg once daily, with maximum daily doses not exceeding 2.5 grams. Administration should occur at the same time each day, preferably with food to minimize gastrointestinal discomfort. Tablets should be swallowed whole with water and not crushed or chewed. Dosage adjustments are necessary for patients with renal impairment, with recommendations to reduce frequency to 2-3 times per week based on creatinine clearance.
Precautions
Baseline and monthly ophthalmologic examinations are mandatory due to the risk of optic neuritis. Renal function should be assessed before initiation and monitored periodically throughout treatment. Liver function tests are recommended as ethambutol is partially hepatically metabolized. Use with caution in patients with diabetic retinopathy, cataracts, or other ocular conditions that may complicate visual assessment. Pregnancy category C: use only if potential benefit justifies potential risk to fetus. Not recommended during breastfeeding due to excretion in breast milk.
Contraindications
Hypersensitivity to ethambutol or any component of the formulation. Optic neuritis (unless benefits outweigh risks and no alternative exists). Significant renal impairment with inability to monitor drug levels. Children under 13 years (unless no alternative effective regimen exists and benefits outweigh risks). Uncooperative patients or those unable to report visual symptoms reliably.
Possible side effects
Ocular effects: optic neuritis (dose- and duration-dependent), decreased visual acuity, scotoma, color blindness, visual field defects. Gastrointestinal: nausea, vomiting, abdominal pain, anorexia. Dermatological: rash, pruritus, dermatitis. Neurological: dizziness, headache, confusion, peripheral neuropathy. Miscellaneous: fever, malaise, joint pain, elevated uric acid levels (may precipitate gout). Hepatic: transient elevation of liver enzymes. Hematological: thrombocytopenia, leukopenia.
Drug interaction
Aluminum-containing antacids may decrease ethambutol absorption; administer at least 2 hours apart. Neurotoxic drugs (isoniazid, chloroquine, hydroxychloroquine) may increase risk of neurological side effects. May decrease renal excretion of uric acid; use with caution in patients on uricosuric agents. No significant interactions with cytochrome P450 system. Potential additive hepatotoxicity when combined with other antituberculosis drugs.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Consistent daily administration is critical for therapeutic efficacy and resistance prevention. Patients should maintain a medication diary or use pill organizers to improve adherence. Report persistent adherence issues to healthcare provider for management strategy adjustment.
Overdose
Symptoms may include nausea, vomiting, abdominal pain, dizziness, and visual disturbances. In severe cases, optic neuritis and metabolic acidosis may occur. There is no specific antidote. Management includes gastric lavage if presented early, supportive care, and monitoring of visual function. Hemodialysis may enhance elimination in patients with renal impairment. Ophthalmic evaluation is mandatory following suspected overdose.
Storage
Store at controlled room temperature (20-25°C or 68-77°F). Protect from light and moisture. Keep in original container with tight closure. Do not store in bathroom or near kitchen sink. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Properly dispose of unused medication through take-back programs or according to local regulations.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment recommendations. Dosage and treatment duration must be determined by a physician based on individual patient factors. Never initiate, adjust, or discontinue medication without professional guidance.
Reviews
Clinical studies demonstrate ethambutol’s efficacy in combination therapy, with success rates exceeding 95% in drug-susceptible tuberculosis when protocol-adherent. Ophthalmologic complications occur in approximately 1-2% of patients at recommended doses, increasing with higher doses and prolonged therapy. Most side effects are reversible upon discontinuation if detected early. The drug is generally well-tolerated with proper monitoring. Professional guidelines consistently recommend ethambutol as a first-line agent for tuberculosis treatment in appropriate patient populations.